The pharmaceutical world is observing a significant shift in diabetes therapy with the emergence of GLP-1 skin applications. These systems offer a seemingly more convenient alternative to subcutaneous administrations of GLP-1 drugs, lessening the requirement of daily needle sticks. The technology administers the drug directly through the skin, p… Read More